RecruitingNot Applicable

Clinical Trial of Concomitant Hip Arthroscopy During PAO

United States106 participantsStarted 2017-08-23

Plain-language summary

The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.

Who can participate

Age range15 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment * Skeletally mature * Age 15 - 55 * Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis) * Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip Exclusion Criteria: * Pregnant women * Previous surgery about the hip * Patients receiving PAO for acetabular retroversion in the absence of DDH * Previous hip arthroscopy to address intra-articular pathology

What they're measuring

Mean score of Hip Disability and Osteoarthritis Outcome (Hoos)

Timeframe: 1 year follow-up time point

Mean score of Western Ontario and McMaster Universities Arthritis Index (WOMAC)

Timeframe: 1 year follow-up time point

Mean score of University California Los Angeles (UCLA) activity assessment

Timeframe: 1 year follow-up time point

Mean score of the Marx Activity Scale (MARX)

Timeframe: 1 year follow-up time point

Trial details

NCT IDNCT03181048

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-06

Contact for this trial

Cody Wyles, MD

(507) 284-1175 wyles.cody@mayo.edu

View on ClinicalTrials.gov More Hip Dysplasia trials